Guillena, Concepcion M.
HRN: 09-88-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/07/2023
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
10/07/2023
10/13/2023
IV
500mg
Q24
Complicated UTI
Checking Final Appropriateness
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes